Illumina, Inc.
看多

Waiting on $ILMN to recross 50EMA on the daily.

67
Most biotechs are set to rally into 2023 following suppression and release of XBI through institutional channels. Components inside of XBI that initially contributed to its rise and gains over the years will be the source to start the process again.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。